Falsey AR, Hosman T, Bastian AR, Vandenberghe S, et al. Long-term efficacy and immunogenicity of Ad26.RSV.preF-RSV preF protein vaccine
(CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study. Lancet Infect Dis 2024;24:1015-1024.
PMID: 38801826
|